Zentiva
The role involves developing and executing market access strategies for pharmaceutical products across Europe, focusing on navigating health technology assessments, negotiations, and stakeholder relationships to ensure optimal market access and reimbursement.
Headquarters
Dolní Měcholupy, Prague, Czechia
Company Size
1001-5000 employees
Founded
1488
We develop, produce, and deliver high-quality, affordable medicines to more than 100 million people across Europe.
Zentiva, a leading European generics pharmaceutical company, announces sale from Advent to GTCR
Sep 11, 2025
European generics firm Zentiva sold in $4.8bn private equity deal
Sep 16, 2025
Private equity firm Advent to sell generic drugmaker Zentiva to GTCR
Sep 11, 2025
Headquarters
San Francisco, CA
Company Size
201-500 employees
Founded
2018
Industry
Technology
Glassdoor Rating
4.2 / 5
Sarah Johnson
Chief Executive Officer
Michael Chen
Chief Technology Officer
Emily Williams
VP of Engineering
David Rodriguez
VP of Product
Jessica Thompson
Chief Financial Officer
Andrew Park
VP of Sales
View leadership team, funding history,
and employee contacts for Zentiva.
Zentiva didn’t post a salary, so this is our estimate from similar listings.
5% above the average for this role
Chicago private equity firm inks €4.1B purchase of former Sanofi generics unit Zentiva: FT
Sep 11, 2025
Market Access Manager
Digital Biology
Senior Director, Pricing and Market Access, Europe
Revolution Medicines
Senior Director, Market Access, Spain
Revolution Medicines
Consultant - Pricing & Market Access
IQVIA
Consultant, Advisory Global Market Access and Pricing
Avalere Health
Regional Market Access & Pricing Manager
Lundbeck